Sarah Beck

2.1k total citations · 1 hit paper
30 papers, 1.0k citations indexed

About

Sarah Beck is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Sarah Beck has authored 30 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 11 papers in Pulmonary and Respiratory Medicine and 7 papers in Immunology and Allergy. Recurrent topics in Sarah Beck's work include Platelet Disorders and Treatments (19 papers), Blood properties and coagulation (8 papers) and Cell Adhesion Molecules Research (7 papers). Sarah Beck is often cited by papers focused on Platelet Disorders and Treatments (19 papers), Blood properties and coagulation (8 papers) and Cell Adhesion Molecules Research (7 papers). Sarah Beck collaborates with scholars based in Germany, United Kingdom and United States. Sarah Beck's co-authors include Teresa Klinowska, Paul R. Gavine, Elaine Kilgour, Dawn Baker, Tanya Coleman, Andrew P. Thomas, Lorraine Mooney, Katherine Al-Kadhimi, Martine J. Mellor and Bernhard Nieswandt and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Cancer Research.

In The Last Decade

Sarah Beck

29 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

AZD4547: An Orally Bioavailable, Potent, and Selective Inhibitor of the Fibroblast Growth Factor Receptor Tyrosine Kinase Family

2012 415 citations Paul R. Gavine, Lorraine Mooney et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarah Beck Germany	16	534	258	203	199	106	30	1.0k
Shiro Koizume Japan	18	487 0.9×	224 0.9×	170 0.8×	126 0.6×	92 0.9×	37	1.0k
David Cervi United States	13	554 1.0×	281 1.1×	377 1.9×	104 0.5×	128 1.2×	21	948
Kevin S. Choe United States	15	352 0.7×	188 0.7×	314 1.5×	271 1.4×	61 0.6×	31	1.0k
Irma M. Sáinz United States	16	236 0.4×	188 0.7×	117 0.6×	125 0.6×	146 1.4×	25	741
Behrouz Zand United States	12	364 0.7×	83 0.3×	350 1.7×	86 0.4×	204 1.9×	34	869
Sonia Caccia Italy	21	351 0.7×	518 2.0×	81 0.4×	90 0.5×	223 2.1×	38	1.3k
Veronica A. Carroll United Kingdom	15	595 1.1×	99 0.4×	160 0.8×	158 0.8×	125 1.2×	23	1.1k
Brian Riesenberg United States	13	317 0.6×	91 0.4×	356 1.8×	85 0.4×	321 3.0×	17	857
Brett H. Herzog United States	12	333 0.6×	121 0.5×	631 3.1×	116 0.6×	383 3.6×	17	1.1k
Jialiang Wang China	18	742 1.4×	173 0.7×	211 1.0×	107 0.5×	55 0.5×	29	950

Countries citing papers authored by Sarah Beck

Since Specialization

Citations

This map shows the geographic impact of Sarah Beck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Beck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Beck more than expected).

Fields of papers citing papers by Sarah Beck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Beck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Beck. The network helps show where Sarah Beck may publish in the future.

Co-authorship network of co-authors of Sarah Beck

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Beck. A scholar is included among the top collaborators of Sarah Beck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Beck. Sarah Beck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schrottmaier, Waltraud C., Hubert Hackl, Sarah Beck, et al.. (2024). Impaired hemostatic and immune functions of platelets after acute thrombocytopenia. Journal of Thrombosis and Haemostasis. 23(3). 1052–1065. 1 indexed citations

Herrmann, Johannes, et al.. (2024). Extracorporeal membrane oxygenation aggravates platelet glycoprotein V shedding and δ-granule deficiency in COVID-19–associated acute respiratory distress syndrome. Journal of Thrombosis and Haemostasis. 22(8). 2316–2330.

Beck, Sarah, Ying Di, Steven G. Thomas, et al.. (2023). Antibody-mediated depletion of human CLEC-2 in a novel humanized mouse model. Blood Advances. 7(6). 997–1000. 4 indexed citations

Hackenbroch, Carsten, Carina Gross, Tolga Çimen, et al.. (2023). OC 49.5 Platelet-Derived LTB4 Mediates Neutrophil Recruitment. Research and Practice in Thrombosis and Haemostasis. 7. 100491–100491. 1 indexed citations

Beck, Sarah, Renhao Li, Katherina Hemmen, et al.. (2023). Platelet glycoprotein V spatio-temporally controls fibrin formation. Nature Cardiovascular Research. 2(4). 368–382. 11 indexed citations

Beck, Sarah, Bernhard Hochreiter, & Johannes A. Schmid. (2022). Extracellular Vesicles Linking Inflammation, Cancer and Thrombotic Risks. Frontiers in Cell and Developmental Biology. 10. 859863–859863. 29 indexed citations

Stegner, David, Sarah Beck, Katherina Hemmen, et al.. (2022). Foudroyant cerebral venous (sinus) thrombosis triggered through CLEC-2 and GPIIb/IIIa dependent platelet activation. Nature Cardiovascular Research. 1(2). 132–141. 15 indexed citations

Beck, Sarah, David Stegner, Stefan Loroch, et al.. (2021). Generation of a humanized FXII knock‐in mouse—A powerful model system to test novel anti‐thrombotic agents. Journal of Thrombosis and Haemostasis. 19(11). 2835–2840. 2 indexed citations

Becker, Isabelle C., Sarah Beck, Georgi Manukjan, et al.. (2020). Actin/microtubule crosstalk during platelet biogenesis in mice is critically regulated by Twinfilin1 and Cofilin1. Blood Advances. 4(10). 2124–2134. 18 indexed citations

10.

Volz, Julia, Sarah Beck, Michael P. Popp, et al.. (2020). BIN2 orchestrates platelet calcium signaling in thrombosis and thrombo-inflammation. Journal of Clinical Investigation. 130(11). 6064–6079. 23 indexed citations

11.

Volz, Julia, Sarah Beck, Sheila Bryson, et al.. (2019). Platelet lamellipodium formation is not required for thrombus formation and stability. Blood. 134(25). 2318–2329. 33 indexed citations

12.

Stritt, Simon, Sarah Beck, Bing Peng, et al.. (2019). Coactosin-like 1 integrates signaling critical for shear-dependent thrombus formation in mouse platelets. Haematologica. 105(6). 1667–1676. 7 indexed citations

13.

Beck, Sarah, Michael Leitges, & David Stegner. (2017). Protein kinase Cι/λ is dispensable for platelet function in thrombosis and hemostasis in mice. Cellular Signalling. 38. 223–229. 4 indexed citations

14.

Haining, Elizabeth J., Deya Cherpokova, Karen Wolf, et al.. (2017). CLEC-2 contributes to hemostasis independently of classical hemITAM signaling in mice. Blood. 130(20). 2224–2228. 39 indexed citations

15.

Stritt, Simon, Sarah Beck, Isabelle C. Becker, et al.. (2017). Twinfilin 2a regulates platelet reactivity and turnover in mice. Blood. 130(15). 1746–1756. 24 indexed citations

16.

Eeuwijk, Judith M.M. van, David Stegner, David Lamb, et al.. (2016). The Novel Oral Syk Inhibitor, Bl1002494, Protects Mice From Arterial Thrombosis and Thromboinflammatory Brain Infarction. Arteriosclerosis Thrombosis and Vascular Biology. 36(6). 1247–1253. 60 indexed citations

17.

Gavine, Paul R., Lorraine Mooney, Elaine Kilgour, et al.. (2012). AZD4547: An Orally Bioavailable, Potent, and Selective Inhibitor of the Fibroblast Growth Factor Receptor Tyrosine Kinase Family. Cancer Research. 72(8). 2045–2056. 415 indexed citations breakdown →

18.

Gavine, Paul R., Lorraine Mooney, Elaine Kilgour, et al.. (2011). Abstract 3568: Characterization of AZD4547: An orally bioavailable, potent and selective inhibitor of FGFR tyrosine kinases 1, 2 and 3. Cancer Research. 71(8_Supplement). 3568–3568. 11 indexed citations

19.

Hickinson, D. Mark, Teresa Klinowska, Georgina Speake, et al.. (2010). AZD8931, an Equipotent, Reversible Inhibitor of Signaling by Epidermal Growth Factor Receptor, ERBB2 (HER2), and ERBB3: A Unique Agent for Simultaneous ERBB Receptor Blockade in Cancer. Clinical Cancer Research. 16(4). 1159–1169. 95 indexed citations

20.

Hendriks, Bart S., Gareth Griffiths, Rod Benson, et al.. (2006). Decreased internalisation of ErbB1 mutants in lung cancer is linked with a mechanism conferring sensitivity to gefitinib. PubMed. 153(6). 457–457. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact